Your money or your life: Patient on $50,000-a-week cancer drug fears leaving behind huge medical debt

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the bills.

Related Keywords

Texas ,United States ,Columbus ,Ohio ,White House ,District Of Columbia ,Sebastien Desprez ,Lamy Leach ,Stacie Dusetzina ,Merith Basey ,Paul Davis ,Emily Henderson ,Arthurg James ,Hagop Kantarjian ,Elizabeth Moreno ,Cancer Research Industry ,Vanderbilt University Medical Center ,Blanchard Valley Health System In Findlay ,Md Anderson Cancer Center ,Blanchard Valley Health System ,Cancer Research ,Department Of Leukemia ,Cancer Hospital ,Blanchard Valley ,Research Industry Focus ,Valley Health System ,England Based Immunocore ,Cancer Center ,Affordable Drugs ,Cancer ,Drugs ,Eye ,Eye Cancer ,Health Care ,Hospital ,Liver ,Medicare ,Melanoma ,Stress ,Urine Test ,